These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1692993)

  • 1. Cerebrospinal fluid levels of immunoreactive substance P and somatostatin in patients with multiple sclerosis and inflammatory CNS disease.
    Rösler N; Reuner C; Geiger J; Rissler K; Cramer H
    Peptides; 1990; 11(1):181-3. PubMed ID: 1692993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin-like immunoreactivity and substance-P-like immunoreactivity in the CSF of patients with senile dementia of Alzheimer type, multi-infarct syndrome and communicating hydrocephalus.
    Cramer H; Schaudt D; Rissler K; Strubel D; Warter JM; Kuntzmann F
    J Neurol; 1985; 232(6):346-51. PubMed ID: 2416886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid immunoreactive substance P and somatostatin in neurological patients with peripheral and spinal cord disease.
    Cramer H; Rösler N; Rissler K; Gagnieu MC; Renaud B
    Neuropeptides; 1988 Oct; 12(3):119-24. PubMed ID: 2468107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoreactive substance P and somatostatin in the cerebrospinal fluid of senile parkinsonian patients.
    Cramer H; Rissler K; Rösler N; Strubel D; Schaudt D; Kuntzmann F
    Eur Neurol; 1989; 29(1):1-5. PubMed ID: 2468498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human cerebrospinal fluid somatostatin in neurologic disease.
    Beal MF; Mazurek MF; Black PM; Martin JB
    J Neurol Sci; 1985 Nov; 71(1):91-104. PubMed ID: 2868070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid (CSF) neuropeptide Y- and somatostatin-like immunoreactivities in man.
    Maeda K; Yasuda M; Kaneda H; Maeda S; Yamadori A
    Neuropeptides; 1994 Dec; 27(6):323-32. PubMed ID: 7898640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low somatostatin content in cerebrospinal fluid in multiple sclerosis. An indicator of disease activity?
    Sørensen KV; Christensen SE; Dupont E; Hansen AP; Pedersen E; Orskov H
    Acta Neurol Scand; 1980 Mar; 61(3):186-91. PubMed ID: 6104886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ventricular fluid neuropeptides in Parkinson's disease. I. Levels and distribution of somatostatin-like immunoreactivity.
    Jost S; Reuner C; Mohadjer M; Mundinger F; Cramer H
    Neuropeptides; 1990 Apr; 15(4):219-25. PubMed ID: 1979661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substance P in human cerebrospinal fluid: reductions in peripheral neuropathy and autonomic dysfunction.
    Nutt JG; Mrox EA; Leeman SE; Williams AC; Engel WK; Chase TN
    Neurology; 1980 Dec; 30(12):1280-5. PubMed ID: 6161319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lumbar cerebrospinal fluid concentrations of somatostatin and neuropeptide Y in multiple sclerosis.
    Vécsei L; Csala B; Widerlöv E; Ekman R; Czopf J; Pàlffy G
    Brain Res Bull; 1990 Sep; 25(3):411-3. PubMed ID: 1981332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substance P-like immunoreactivity and somatostatin-like immunoreactivity in the ventricular fluid of patients with chronic pain syndromes.
    Jost S; Reuner C; Geiger J; Mohadjer M; Milios E; Cramer H
    Eur Arch Psychiatry Clin Neurosci; 1991; 241(2):109-12. PubMed ID: 1834180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin in multiple sclerosis.
    Sørensen KV
    Acta Neurol Scand; 1987 Mar; 75(3):161-7. PubMed ID: 2883805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance P mechanism in cluster headache: evaluation in plasma and cerebrospinal fluid.
    Sicuteri F; Fanciullacci M; Geppetti P; Renzi D; Caleri D; Spillantini MG
    Cephalalgia; 1985 Sep; 5(3):143-9. PubMed ID: 2412704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated cerebrospinal fluid substance P-like immunoreactivity in patients with painful osteoarthritis, but not in patients with rhizopatic pain from a herniated lumbar disc.
    Lindh C; Liu Z; Lyrenäs S; Ordeberg G; Nyberg F
    Scand J Rheumatol; 1997; 26(6):468-72. PubMed ID: 9433409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CSF substance P somatostatin and monoaminergic transmitter metabolites in patients with narcolepsy.
    Strittmatter M; Isenberg E; Grauer MT; Hamann G; Schimrigk K
    Neurosci Lett; 1996 Nov; 218(2):99-102. PubMed ID: 8945737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular forms of somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with senile dementia of the Alzheimer type.
    Strittmatter M; Cramer H; Reuner C; Strubel D; Hamann G; Schimrigk K
    Biol Psychiatry; 1997 Jun; 41(11):1124-30. PubMed ID: 9146823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the concentration of somatostatin and substance P in the cerebrospinal fluid following injection of alcohol into the pituitary gland.
    Conlon JM; Lahuerta J; Miles J; Lipton S
    Neuropeptides; 1984 May; 4(3):227-36. PubMed ID: 6205318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular size distribution of somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with degenerative brain disease.
    Rissler K; Cramer H; Schaudt D; Strubel D; Gattaz WF
    Neurosci Res; 1986 Feb; 3(3):213-25. PubMed ID: 2871533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High resolution proton MR spectroscopy of cerebrospinal fluid in MS patients. Comparison with biochemical changes in demyelinating plaques.
    Simone IL; Federico F; Trojano M; Tortorella C; Liguori M; Giannini P; Picciola E; Natile G; Livrea P
    J Neurol Sci; 1996 Dec; 144(1-2):182-90. PubMed ID: 8994122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Objective evaluation of pain in various spinal diseases: neuropeptide immunoreactivity in the cerebrospinal fluid.
    Imasato H; Nagata K; Hashimoto S; Komori H; Inoue A
    Spinal Cord; 1997 Nov; 35(11):757-62. PubMed ID: 9392047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.